X

Blog

Arrayit Corp. (ARYC.OB) Wins Equipment Contract from Sandia National Laboratories

Arrayit Corp., a developer and manufacturer of proprietary life science technologies and consumables for disease prevention, treatment and cure, recently…

QualityStocks

Nutra Pharma (NPHC.OB) Announces Pertinent Product Information

Nutra Pharma has announced their intention to begin the registration for their over-the-counter pain reliever in both Canada and Europe.…

QualityStocks

September 21st CEOcast Weekly Newsletter

Companies featured in this edition of the newsletter: ACTC, CVM, CUR, DKAM, ENZ, IMUC, IWEB, PHC, SVUL, SRCO, SVUL, XSNX…

QualityStocks

Manhattan Scientifics Inc. (MHTX.OB) Inks Licensing Agreement with Carpenter Technology

Manhattan Scientifics Inc. capitalizes on inventions and technology by earning profits through licensing. It identifies, develops, patents, supports and markets…

QualityStocks

Axial Vector Energy Corp. (AXVC.PK) Describes Dual Technologies of Petrosonics

Axial Vector Energy Corp., developer of advanced, high-efficiency energy engines, has access to two important fuel purification technologies associated with…

QualityStocks

Neuralstem, Inc. (CUR) Receives FDA Approval to Begin First ALS Stem Cell Trial

Neuralstem Inc. has patented technology which enables, for the first time, the ability to produce neural stem cells of the…

QualityStocks

Consorteum Holdings, Inc. (CSRH.OB) Sees Significant Opportunity in the United Arab Emirates

Consorteum Holdings Inc. is an international company focused on the financial services, payment and transaction processing industry. The company provides…

QualityStocks

DOR BioPharma Inc. (DORB.OB) Earns $9.4 Million NIH Grant

DOR BioPharma Inc. is a late-stage biotechnology company that has been gaining national attention for its state-of-the-art technology. DOR reached…

QualityStocks

GlaxoSmithKline (GSK) and XenoPort, Inc. (XNPT) Report Positive Results from Clinical Trial

Friday, GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (NASDAQ:XNPT) announced top-line results from a Phase II-b clinical trial. The study evaluates the…

QualityStocks

Speedus Corp. (SPDE) Subsidiary Receives Clearance to Market Signal X6 Device

Siemens Corporate Research spin-off and Speedus Corp. subsidiary, Zargis Medical Corp., announced Friday that it has received U.S. Food and…

QualityStocks